Crysforma provides complete scientific support for the discovery, analysis and scale-up of polymorphs, hydrates, amorphous phases, salts and co-crystals of active pharmaceutical ingredients or intermediates.
Crysforma has developed its own crystallization screening methodology based on the combination of several crystallization procedures. We use high-throughput crystallization systems controlled by highly skilled scientists to maximize the information drawn from each experiment (read more).
- Crysforma has worked for many years to reach international industrial partners. During 2017, nearly 45% of the income generated by Crysforma came from international collaborations. Crysforma collaborated with companies from Germany, China, the Netherlands or Ireland, among others.